title: Prevention of gastric cancer with antibiotics: can it be done without eradicating Helicobacter pylori?
authors.affiliation: Affiliation of authors: Division of Digestive and Liver Diseases, Columbia University Medical Center, New York, NY (DEF, JAA, TCW). def2004@cumc.columbia.edu.
authors.forename: Daniel E
authors.initials: DE
authors.lastname: Freedberg
authors.affiliation: Affiliation of authors: Division of Digestive and Liver Diseases, Columbia University Medical Center, New York, NY (DEF, JAA, TCW).
authors.forename: Julian A
authors.initials: JA
authors.lastname: Abrams
authors.affiliation: Affiliation of authors: Division of Digestive and Liver Diseases, Columbia University Medical Center, New York, NY (DEF, JAA, TCW).
authors.forename: Timothy C
authors.initials: TC
authors.lastname: Wang
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D005260:Female; D016481:Helicobacter Infections / Q000188:drug therapy*; D016480:Helicobacter pylori / Q000187:drug effects*; D006801:Humans; D008297:Male; D011230:Precancerous Conditions / Q000188:drug therapy*; D013274:Stomach Neoplasms / Q000453:epidemiology* / Q000517:prevention & control*
chemical_list: D000900:Anti-Bacterial Agents